PI Industries Q4 2026 Results: PAT Falls 31% YoY, Announced ₹10 Dividend
PI Industries reported mixed Q4 FY26 performance with lower profit and revenue on a yearly basis, while the pharma segment posted strong growth and the board announced a final dividend of ₹10 per share.
Quick Summary
PI Industries Q4 Results: The company reported consolidated revenue from operations of ₹1,565.20 crore in Q4 FY26, down 12.42% YoY. Consolidated net profit stood at ₹200.20 crore, while the board recommended a final dividend of ₹10 per share.
PI Industries Q4 2026 Results: On 19 May 2026, PI Industries reported higher revenue in March quarter, driven by growth in its agrochemicals business and improved operational performance.
However, consolidated net profit declined 35.69% quarter-on-quarter and 31.32% year-on-year during March quarter.
PI Industries Q4 Results Highlights
PI Industries reported better operational performance during the March quarter, though earnings remained under pressure
|
Metric |
Q4 FY26 |
Q3 FY26 |
QoQ% |
Q4 FY25 |
YoY% |
|
Revenue from Ops (₹ Cr) |
1,565.20 |
1,375.70 |
13.77% |
1,787.10 |
-12.42% |
|
Total Income (₹ Cr) |
1,640.80 |
1,442.40 |
13.76% |
1,860.50 |
-11.81% |
|
Net Profit (₹ Cr) |
200.20 |
311.30 |
-35.69% |
330.50 |
-31.32% |
Source: NSE filing, PI Industries FY26 Consolidated Annual Results
-
Consolidated revenue from operations for Q4 FY26 stood at ₹1,565.20 crore, compared to ₹1,787.10 crore in Q4 FY25 and ₹1,375.70 crore in Q3 FY26. Revenue rose 13.77% quarter-on-quarter, while on a year-on-year basis the company reported a decline of 12.42%.
-
Total income came in at ₹1,640.80 crore during the quarter against ₹1,860.50 crore in Q4 FY25 and ₹1,442.40 crore in Q3 FY26. Total income increased 13.76% from last quarter but declined 11.81% YoY.
-
Consolidated profit after tax for the quarter stood at ₹200.20 crore against ₹311.30 crore in Q3 FY26 and ₹330 crore in Q4 FY25. Profit declined 31.32% YoY and 35.69% QoQ.
PI Industries' Segment-wise Revenue
Agro Chemicals segment remained the largest contributor to PI Industries’ revenue during Q4 FY26. Pharma segment reported healthy growth during the quarter, partially offsetting weakness in the agrochemicals business.
|
Segment |
Q4 FY26 |
Q4 FY25 |
YoY % |
|
Agro Chemicals (₹ Cr) |
1,461.20 |
1,703.10 |
-14.20% |
|
Pharma (₹ Cr) |
104.80 |
85.00 |
23.29% |
PI Industries' Full-Year Performance Remained Weak
PI Industries reported lower earnings and revenue during FY26 due to weakness in parts of the agrochemical value chain.
|
Metric |
FY26 |
FY25 |
YoY Change |
|
Consolidated Revenue (₹ Cr) |
6,713.70 |
7,977.80 |
-15.84% |
|
Consolidated Net Profit (₹ Cr) |
1320.80 |
1660.20 |
-20.44% |
|
Operating Cash Flow (₹ Cr) |
474.00 |
1412.90 |
-66.45% |
Source: NSE filing, PI Industries FY26 Consolidated Annual Results
Read detailed MapmyIndia quarterly results and dividend updates
PI Industries Dividend 2026 and Stock Performance
PI Industries’ board recommended a final dividend of ₹10 per equity share with a face value of Re 1 each for FY26. Including the interim dividend of ₹5 per share already paid during the year, the total dividend for FY26 stands at ₹15 per share.
As of 19 May, 3.30 PM
Ahead of the results, PI Industries shares closed 0.78% higher. On a year-to-date (YTD) basis, PIIND stock is down nearly 3%. Over the one-year period from 19 May 2025 to 19 May 2026, PI Industries shares have declined around 17%.